UK-122802 (Pfizer)

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameUK-122802 (Pfizer)
Drug Alias NameUK-122802
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytochrome P450 inhibitors
TargetsCytochrome P450
Therapy Area/IndicationsHyperlipidemiasAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsHyperlipidemiasAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A